We are live on
!
Find out more
FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$434M
1-Year Est. Return
9.09%
This Fund
S&P 500
This Quarter
Est. Return
-9.87%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$496M
AUM Growth
-$89.5M
(-15%)
Cap. Flow
-$30.4M
Cap. Flow
% of AUM
-6.12%
Top 10 Holdings %
Top 10 Hldgs %
53.18%
Holding
63
New
5
Increased
14
Reduced
30
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$4.38M |
| 2 |
Linde
LIN
|
+$3.33M |
| 3 |
Copart
CPRT
|
+$1.75M |
| 4 |
Valvoline
VVV
|
+$1.56M |
| 5 |
MRSH
Marsh
MRSH
|
+$1.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$7.35M |
| 2 |
Medtronic
MDT
|
+$6.6M |
| 3 |
Union Pacific
UNP
|
+$5.57M |
| 4 |
PX
Praxair Inc
PX
|
+$3.81M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$2.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.16% |
| 2 | Technology | 18.59% |
| 3 | Financials | 12.44% |
| 4 | Industrials | 12.37% |
| 5 | Consumer Staples | 12.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
AbbVie
ABBV
$455B
| $1.13M | 0.23% |
12,200
| – | – |
|
|
CHL
52
DELISTED
China Mobile Limited
CHL
| $1.09M | 0.22% |
22,650
+3,396
| +18% | +$164K |
|
53
Abbott
ABT
$183B
| $926K | 0.19% |
12,800
| – | – |
|
54
Copa Holdings
CPA
$5.8B
| $854K | 0.17% |
10,851
+3,496
| +48% | +$274K |
|
55
Kraft Heinz
KHC
$31.3B
| $793K | 0.16% |
18,418
| – | – |
|
56
Procter & Gamble
PG
$335B
| $494K | 0.1% |
5,377
| – | – |
|
57
Compañía de Cervecerías Unidas
CCU
$2.16B
| $470K | 0.09% |
18,711
-30,780
| -62% | -$796K |
|
58
ExxonMobil
XOM
$651B
| $279K | 0.06% |
4,095
| – | – |
|
59
Vanguard S&P 500 ETF
VOO
$972B
| $205K | 0.04% |
+893
| New | +$221K |
|
60
Emerson Electric
EMR
$83.3B
| – | – |
-36,168
| Closed | -$2.77M |
|
|
61
L3Harris
LHX
$50.7B
| – | – |
-43,439
| Closed | -$7.35M |
|
|
PTR
62
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| – | – |
-7,432
| Closed | -$605K |
|
|
PX
63
DELISTED
Praxair Inc
PX
| – | – |
-23,683
| Closed | -$3.81M |
|
Similar funds
HCM
GS
IA
PAMS
SSWG
JWM
GDS
GPP
Foyston, Gordon, & Payne's Q4 2018 Portfolio in Review
As of Q4 2018, Foyston, Gordon, & Payne held 63 positions worth $496M, down 15% from $586M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $30.4M in Q4 2018, closing 4 positions and reducing 30 holdings. Its most notable exit was L3Harris, an estimated $7.35M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.
Against the trend, Foyston, Gordon, & Payne opened a new position in Sanofi worth $4.31M.
- Foyston, Gordon, & Payne's largest Q4 2018 buy was Sanofi: 99,300 shares worth $4.31M.
- Foyston, Gordon, & Payne added most to Valvoline in Q4 2018, an estimated $1.56M increase.
- Foyston, Gordon, & Payne's biggest Q4 2018 reduction was Medtronic, cutting an estimated $6.6M.
- Foyston, Gordon, & Payne fully exited L3Harris in Q4 2018, selling an estimated $7.35M.
- Foyston, Gordon, & Payne's ten largest holdings make up 53% of its $496M portfolio in Q4 2018.
- Foyston, Gordon, & Payne opened 5 new positions and closed 4 in Q4 2018.
- Foyston, Gordon, & Payne's portfolio value fell 15% quarter-over-quarter to $496M.
Based on Foyston, Gordon, & Payne's 13F filing for Q4 2018, filed 8 Feb 2019.